This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International Europe
12-15 May 2025
Congress Center HamburgHamburg, Germany

Stephane Busso
CLD Scientist, Biopharmaceutical Product Development at Fresenius Kabi
Speaker

Profile

I’m an experienced scientist specializing in cell line development, with over 20 years in the biopharmaceutical industry. With a strong background in novel biologics (NBEs), I’m currently focused on the development and optimization of biosimilars at Fresenius Kabi. My work encompasses various aspects of molecular biology, cell line development and regulatory compliance, reflecting my commitment to advancing therapeutic solutions in the biotechnology field.

Agenda Sessions

  • Biosimilar: A CLD approach to increase clone diversity

    09:30